Chemed Valuation
| CXM Stock | EUR 400.00 6.00 1.52% |
At this time, the firm appears to be fairly valued. Chemed shows a prevailing Real Value of €387.68 per share. The current price of the firm is €400.0. Our model approximates the value of Chemed from analyzing the firm fundamentals such as profit margin of 0.11 %, and Return On Equity of 0.24 as well as examining its technical indicators and probability of bankruptcy.
Price Book 5.3602 | Enterprise Value 5.6 B | Enterprise Value Ebitda 13.9751 | Price Sales 2.3013 | Forward PE 17.5439 |
Fairly Valued
Today
Please note that Chemed's price fluctuation is very steady at this time. Calculation of the real value of Chemed is based on 3 months time horizon. Increasing Chemed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Chemed stock is determined by what a typical buyer is willing to pay for full or partial control of Chemed. Since Chemed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Chemed Stock. However, Chemed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 400.0 | Real 387.68 | Hype 400.72 | Naive 419.53 |
The real value of Chemed Stock, also known as its intrinsic value, is the underlying worth of Chemed Company, which is reflected in its stock price. It is based on Chemed's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Chemed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Chemed helps investors to forecast how Chemed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Chemed more accurately as focusing exclusively on Chemed's fundamentals will not take into account other important factors: Chemed Cash |
|
Chemed Total Value Analysis
Chemed is currently estimated to have takeover price of 5.61 B with market capitalization of 5.82 B, debt of 549.58 M, and cash on hands of 3.32 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Chemed fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.61 B | 5.82 B | 549.58 M | 3.32 M |
Chemed Investor Information
About 97.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 1.75. Chemed recorded earning per share (EPS) of 15.96. The entity last dividend was issued on the 23rd of February 2026. Based on the measurements of operating efficiency obtained from Chemed's historical financial statements, Chemed is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 302.4 M | 480.1 M |
|
| |||||
| Operating Income | 304 M | 422 M |
|
|
Chemed Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Chemed has an asset utilization ratio of 145.71 percent. This implies that the Company is making €1.46 for each dollar of assets. An increasing asset utilization means that Chemed is more efficient with each dollar of assets it utilizes for everyday operations.Chemed Profitability Analysis
Based on the measurements of profitability obtained from Chemed's financial statements, Chemed may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Chemed's ability to earn profits and add value for shareholders.Net Income | First Reported 2016-12-31 | Previous Quarter 52.5 M | Current Value 64.2 M | Quarterly Volatility 21.6 M |
For Chemed profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Chemed to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Chemed utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Chemed's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Chemed over time as well as its relative position and ranking within its peers.
Chemed Earnings per Share Projection vs Actual
By analyzing Chemed's earnings estimates, investors can diagnose different trends across Chemed's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Chemed is based on EPS before non-recurring items and includes expenses related to employee stock options.Chemed Ownership Allocation
Chemed retains a total of 14.11 Million outstanding shares. The majority of Chemed outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Chemed to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Chemed. Please pay attention to any change in the institutional holdings of Chemed as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.Chemed Profitability Analysis
The company reported the revenue of 2.43 B. Net Income was 302 M with profit before overhead, payroll, taxes, and interest of 832.13 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Chemed's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Chemed and how it compares across the competition.
About Chemed Valuation
The stock valuation mechanism determines Chemed's current worth on a weekly basis. Our valuation model uses a comparative analysis of Chemed. We calculate exposure to Chemed's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Chemed's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 982.5 M | 691.6 M |
Chemed Quarterly Retained Earnings |
|
Complementary Tools for Chemed Stock analysis
When running Chemed's price analysis, check to measure Chemed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemed is operating at the current time. Most of Chemed's value examination focuses on studying past and present price action to predict the probability of Chemed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemed's price. Additionally, you may evaluate how the addition of Chemed to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stocks Directory Find actively traded stocks across global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |